Skip to main content
SpringerLink
Log in

Cadralazine did not produce the SLE-syndrome when hydralazine did

  • Letters To The Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Parravicini F, Scarpitta G, Dorigotti L, Pifferi G (1979) Derivati della 3-idrazinopiridazina. Farmaco (Sci) 34: 299–310

    Google Scholar 

  2. Catalano M, Parini J, Romano M, Libretti A (1985) Controlled clinical trial of cadralazine as a second-step drug in the treatment of hypertension. Eur J Clin Pharmacol 28: 135–138

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Medicine, University of Göteborg, Sahlgrenska Hospital, Göteborg, Sweden

    O. K. Andersson

Authors
  1. O. K. Andersson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Andersson, O.K. Cadralazine did not produce the SLE-syndrome when hydralazine did. Eur J Clin Pharmacol 31, 741 (1987). https://doi.org/10.1007/BF00541309

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00541309

Key words

Search

Navigation